Allergan, following years of turmoil and resistance, heads for split
19 Jun 2019 //
FIERCE PHARMA
Allergan chief Saunders takes a painful $2.5B hit on an ugly PhIII flop
08 May 2019 //
ENDPTS
Rat study suggests Allergan’s failed antidepressant rapastinel- opioid addiction
09 Apr 2019 //
ENDPTS
Allergan Announces Ph3 Results for Rapastinel as an Adjunctive Treatment (MDD)
06 Mar 2019 //
PR NEWSWIRE